Navigation Links
Medical research on ice

New medical equipment recently delivered to the Antarctic station Concordia will help understand how our bodies physically adapt to this extreme environment - knowledge which could help prepare for a future human mission to Mars. ESA is currently looking for a candidate with a medical background to support projects at the research base.

The Antarctic station Concordia is located in one of the most hostile environments on the Earth. Built on an ice plateau at 3 200 m altitude, exposed to extreme isolation, temperatures, constant light in summer, constant darkness in winter and other stressors, a stay at Concordia is a huge challenge.

Harsh winter

For the up to 16 crewmembers that can be hosted in the station during the Antarctic winter, conditions are even more severe as the harsh environmental conditions make access to or from the station impossible. Any problems that occur need to be dealt with autonomously by the crew with the resources at hand.

Fortunately for ESA, many of the same constraints that naturally occur during the winter at Concordia are quite similar to those that can be expected for future crewed exploration missions, for example to Mars.

For this reason, in 2002, ESA established a cooperation with the builders and operators of the station; the French Polar Institute (Institute Paul Emile Victor, IPEV) and the Italian Antarctic Programme (Consorzio per l'Attuazione del Programma Nazionale di Ricerche in Antartide, PNRA S.C.r.l.). Next to some technology validation, the main focus of this cooperation is on medicine, physiology and psychology.

Long-Term Medical Survey

Together with the Concordia partners and a diverse group of experts, ESA has defined the Long-Term Medical Survey (LTMS); a list of physiological and psychological parameters that is collected by each Concordia crewmember, with the goal of enhancing knowledge about human adaptation in this extreme environment.

To facilitate the collection of physiological data, ESA commissioned the development of an easy-to-use, minimally intrusive, integrated monitoring device, taking into account that the majority of Concordia crewmembers have no medical background. The first prototype was recently shipped to Antarctica and is now being evaluated by the Concordia crew.

Other interesting medical and psychological research is still ongoing at the station. For example, a current project investigates how blood clotting is affected by the high altitude at Concordia. This research is very relevant to understanding the 'economy class syndrome' - the risk of thrombosis when flying long-distance in airplanes. The psychological projects look for example at how the crew adapts to the extreme environment, or how they cope with the challenging situation. This type of research will also continue throughout the coming winter season.


Contact: Markus Bauer
European Space Agency

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm ... appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto ... Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... ... 2015 , ... Since its launch in 2012, the Regenestem ... cell therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent ... (RTM). , Organizations are required to hold a registered trademark in order to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... Pennsylvania , November 25, 2015 - ... Continuing Medical Education (CME) --> ... Continuing Medical Education (CME) --> ... Care Continuing Medical Education (CME) ... medical information products and services, will feature latest diagnostic imaging textbooks ...
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
Breaking Medicine Technology: